pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'lung', 'pembro', 'keynote-671']
nejm group's christine sadlowski and dr. jyoti patel talk to dr. heather wakelee about keynote-671, a trial that tested pembrolizumab as both an adjuvant and a neoadjuvant in treating early non small-cell lung cancer. #asco23 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.